JOURNAL BROWSE
Search
Advanced SearchSearch Tips
mRNA Expression of Bax, Bcl-2, p53, Cathepsin B, Caspase-3 and Caspase-9 in the HepG2 Cell Line Following Induction by a Novel Monoclonal Ab Hep88 mAb: Cross-Talk for Paraptosis and Apoptosis
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
mRNA Expression of Bax, Bcl-2, p53, Cathepsin B, Caspase-3 and Caspase-9 in the HepG2 Cell Line Following Induction by a Novel Monoclonal Ab Hep88 mAb: Cross-Talk for Paraptosis and Apoptosis
Mitupatum, Thantip; Aree, Kalaya; Kittisenachai, Suthathip; Roytrakul, Sittiruk; Puthong, Songchan; Kangsadalampai, Sasichai; Rojpibulstit, Panadda;
  PDF(new window)
 Abstract
Monoclonal antibodies with specific antigens have been widely used as targeted therapy for cancer. Hep88 mAb is a monoclonal antibody which shows specific binding with anti-cancer effects against the HepG2 cell line. However, its mechanisms of action are still not completely understood. We examined cell cycling and apoptosis by flow cytometry and mRNA expression of factors involved in apoptosis and paraptosis in Hep88 mAb-treated HepG2 cells by real-time PCR. The cell-cycle analysis demonstrated that growth-inhibitory activity was associated with G2/M cell cycle arrest. Hep88 mAb induced a significant increase in apoptotic cell populations in a dose- and time-dependent manner. The mRNA expression results also suggested that the process triggered by Hep88 mAb involved up-regulation of tumor suppressor p53, pro-apoptotic Bax, Cathepsin B, Caspase-3 and Caspase-9, with a decrease of anti-apoptotic Bcl-2 - thus confirming paraptosis and apoptosis programmed cell death. These findings represent new insights into the molecular mechanisms underlying the anti-cancer properties of Hep88 mAb in liver cancer cells.
 Keywords
Apoptosis;cell cycle arrest;monoclonal antibody;mRNA expression;paraptosis;
 Language
English
 Cited by
 References
1.
Broker LE, Huisman C, Span SW, et al (2004). Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res, 64, 27-30. crossref(new window)

2.
Chiang KC, Tsui KH, Chung LC, et al (2014). Cisplatin modulates B-cell translocation gene 2 to attenuate cell proliferation of prostate carcinoma cells in both p53-dependent and p53-independent pathways. Sci Rep, 4, 5511.

3.
Chipuk JE, Green DR (2008). How do Bcl-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol, 18, 157-64. crossref(new window)

4.
Darzynkiewicz Z, Halicka HD, Zhao H (2010). Analysis of cellular DNA content by flow and laser scanning cytometry. Adv Exp Med Biol, 676, 137-47. crossref(new window)

5.
Douarre C, Gomez D, Morjani H, et al (2005). Overexpression of Bcl-2 is associated with apoptotic resistance to the G-quadruplex ligand 12459 but is not sufficient to confer resistance to long-term senescence. Nucleic Acids Res, 33, 2192-203. crossref(new window)

6.
Foghsgaard L, Wissing D, Mauch D, et al (2001). Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol, 153, 999-1010. crossref(new window)

7.
Gondi CS, Rao JS (2013). Cathepsin B as a cancer target. Expert Opin Ther Targets, 17, 281-91. crossref(new window)

8.
Green DR, Kroemer G (2009). Cytoplasmic functions of the tumour suppressor p53. Nature, 458, 1127-30. crossref(new window)

9.
Guicciardi ME, Deussing J, Miyoshi H, et al (2000). Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest, 106, 1127-37. crossref(new window)

10.
Joy B, Sivadasan R, Abraham TE, et al (2010). Lysosomal destabilization and Cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Mol Carcinog, 49, 324-36.

11.
Kagedal K, Johansson AC, Johansson U, et al (2005). Lysosomal membrane permeabilization during apoptosis--involvement of Bax? Int J Exp Pathol, 86, 309-21. crossref(new window)

12.
Laohathai K, Bhamarapravati N (1985). Culturing of human hepatocellular carcinoma. A simple and reproducible method. Am J Pathol, 118, 203-8.

13.
Leist M, Jaattela M (2001). Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol, 2, 589-98.

14.
Lin CH, Lu WC, Wang CW, et al (2013). Capsaicin induces cell cycle arrest and apoptosis in human KB cancer cells. BMC Complement Altern Med, 13, 46. crossref(new window)

15.
Malla R, Gopinath S, Alapati K, et al (2010). Downregulation of uPAR and Cathepsin B induces apoptosis via regulation of Bcl-2 and Bax and inhibition of the PI3K/Akt pathway in gliomas. PLoS One, 5, 13731. crossref(new window)

16.
Manochantr S, Puthong S, Gamnarai P, et al (2011). Hep 88mAB induced ultrastructural alteration through apoptosis like program cell death in hepatocellular carcinoma. J Med Assoc Thai, 94, 109-16.

17.
Marchenko ND, Zaika A, Moll UM (2000). Death signal-induced localization of p53 protein to mitochondria. A potential role in apoptotic signaling. J Biol Chem, 275, 16202-12. crossref(new window)

18.
Mitupatum T, Aree K, Kittisenachai S, et al (2015). Hep88mAb-Mediated Paraptosis-Like Apoptosis in HepG2 Cells via Downstream Upregulation and Activation of Caspase-3, Caspase-8 and Caspase-9. Asian Pac J Cancer Prev, 16, 1771-9. crossref(new window)

19.
Nylandsted J, Gyrd-Hansen M, Danielewicz A, et al (2004). Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med, 200, 425-35. crossref(new window)

20.
Puthong S, Rojpibulstit P, Buakeaw A ( 2009). Cytotoxic effect of Hep88 mAb: a novel monoclonal antibody against hepatocellular carcinoma. Thammasat Int J Sc Tech, 14, 95-104.

21.
Rojpibulstit P, Kittisenachai S, Puthong S, et al (2014). Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase. Cancer Cell International, 14.

22.
Sartorius UA, Krammer PH (2002). Upregulation of Bcl-2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines. Int J Cancer, 97, 584-92. crossref(new window)

23.
Sperandio S, de Belle I, Bredesen DE (2000). An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci U S A, 97, 14376-81. crossref(new window)

24.
Sperandio S, Poksay K, de Belle I, et al (2004). Paraptosis:mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ, 11, 1066-75. crossref(new window)

25.
Stankiewicz AR, Lachapelle G, Foo CP, et al (2005). Hsp70 inhibits heat-induced apoptosis upstream of mitochondria by preventing Bax translocation. J Biol Chem, 280, 38729-39. crossref(new window)

26.
Starenki D, Hong SK, Lloyd RV, et al (2014). Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells. Oncogene.

27.
Taghiyev A, Sun D, Gao ZM, et al (2012). Embelin-induced apoptosis of HepG2 human hepatocellular carcinoma cells and blockade of HepG2 cells in the G2/M phase via the mitochondrial pathway. Exp Ther Med, 4, 649-54.

28.
Taurin S, Seyrantepe V, Orlov SN, et al (2002). Proteome analysis and functional expression identify mortalin as an antiapoptotic gene induced by elevation of [Na+]i/[K+]i ratio in cultured vascular smooth muscle cells. Circ Res, 91, 915-22. crossref(new window)

29.
Wadhwa R, Takano S, Kaur K, et al (2006). Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer, 118, 2973-80. crossref(new window)

30.
Walker C, Bottger S, Low B (2006). Mortalin-based cytoplasmic sequestration of p53 in a nonmammalian cancer model. Am J Pathol, 168, 1526-30. crossref(new window)

31.
Walter RB, Raden BW, Kamikura DM, et al (2005). Influence of CD33 expression levels and ITIM-dependent internalization on gemtuzumab ozogamicin-induced cytotoxicity. Blood, 105, 1295-302.

32.
Wang H, Zhang J, Sit WH, et al (2014a). Cordyceps cicadae induces G2/M cell cycle arrest in MHCC97H human hepatocellular carcinoma cells: a proteomic study. Chin Med, 9, 15. crossref(new window)

33.
Wang Y, Ji P, Liu J, et al (2009). Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Mol Cancer, 8, 8. crossref(new window)

34.
Wang YX, Cai H, Jiang G, et al (2014b). Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition. Asian Pac J Cancer Prev, 15, 6791-8. crossref(new window)

35.
Whelan JA, Russell NB, Whelan MA (2003). A method for the absolute quantification of cDNA using real-time PCR. Journal of Immunological Methods, 278, 261-9. crossref(new window)

36.
Wyllie AH, Golstein P (2001). More than one way to go. Proc Natl Acad Sci U S A, 98, 11-3. crossref(new window)